Tortoise Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-565
| Closed | -$77K | – | 566 |
|
|
2020
Q3 | $77K | Hold |
565
| – | – | 0.02% | 196 |
|
|
2020
Q2 | $55K | Sell |
565
-1,700
| -75% | -$142K | 0.01% | 213 |
|
|
2020
Q1 | $106K | Hold |
2,265
| – | – | 0.03% | 168 |
|
|
2019
Q4 | $165K | Hold |
2,265
| – | – | 0.04% | 154 |
|
|
2019
Q3 | $118K | Hold |
2,265
| – | – | 0.03% | 171 |
|
|
2019
Q2 | $114K | Hold |
2,265
| – | – | 0.03% | 183 |
|
|
2019
Q1 | $118K | Hold |
2,265
| – | – | 0.03% | 178 |
|
|
2018
Q4 | $111K | Hold |
2,265
| – | – | 0.03% | 172 |
|
|
2018
Q3 | $148K | Hold |
2,265
| – | – | 0.04% | 162 |
|
|
2018
Q2 | $112K | Sell |
2,265
-1,133
| -33% | -$54.9K | 0.03% | 175 |
|
|
2018
Q1 | $166K | Hold |
3,398
| – | – | 0.05% | 146 |
|
|
2017
Q4 | $143K | Hold |
3,398
| – | – | 0.04% | 155 |
|
|
2017
Q3 | $146K | Hold |
3,398
| – | – | 0.04% | 147 |
|
|
2017
Q2 | $45K | Hold |
3,398
| – | – | 0.01% | 229 |
|
|
2017
Q1 | $45K | Hold |
3,398
| – | – | 0.01% | 210 |
|
|
2016
Q4 | $44K | Hold |
3,398
| – | – | 0.02% | 210 |
|
|
2016
Q3 | $56K | Hold |
3,398
| – | – | 0.02% | 184 |
|
|
2016
Q2 | $42K | Buy |
+3,398
| New | +$42.5K | 0.01% | 213 |
|
Tortoise Investment Management's MYOK Position: Q4 2020 in Review
Tortoise Investment Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 565 shares — an estimated $77K sold.
Tortoise Investment Management first reported a position in MYOK in Q2 2016 and held it in 18 quarters. The position peaked at $166K in Q1 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Tortoise Investment Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Tortoise Investment Management sold 565 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $77K.
- Tortoise Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q2 2016 and held it in 18 quarters.
- Tortoise Investment Management's MyoKardia, Inc. Common Stock position peaked at $166K in Q1 2018.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Tortoise Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.